5 Patents
- US126066362026Treatment of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US125595622026Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites - US124733432025Targeted T Cells with Cytotoxicity Toward Immunosuppressive Cells
The General Hospital Corporation
0 cites - US120494822024Molecular Switch-mediated Control of Engineered Cells
President And Fellows Of Harvard College
0 cites - US118651672024Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites